% | $
Quotes you view appear here for quick access.

POZEN Inc. Message Board

  • play_tow play_tow Apr 18, 2013 2:42 PM Flag

    CEO To Seek Orphan Drug Status for PA

    On Pozen's webcast today, CEO indicated that, in response to some shareholders who fear that the current $1/day pricing strategy wont net investors enough profit, he is considering seeking Orphan drug status, at a daily cost of $1000/day.

    Investors cheered the news, who now foresee shares of POZN rising 1000 fold to $5000/share.

    Shares bumped up 3% in late trading to $5/share.

    I'm just saying (dreaming)..................

6.71+0.04(+0.60%)May 22 4:00 PMEDT